Dr. Marthak has more than 35 years of experience in the field of clinical research. Dr. Marthak is awarded with an MD in Medicine from Dr. Grant Medical College and also possesses a Business Management degree. Dr. Marthak has vast experience in Phase I to Phase-IV clinical trials. He pioneered Phase I studies in India during his 13 year stint with Novartis in early 80s.
He was President – Association of Medical Advisors of Pharmaceutical Industry and an Executive Committee Member – International Federation of Association of Pharmaceutical Physicians as well as a Board Member for designing the modules for Academy of Clinical Research, Chief organizer of the International conference of Clinical Research held by CII-New Delhi in the year 2002 and a member of the Faculty for Pharmaceutical medicine – University of London, Fellow member – American College of Chest Physician, Fellow member – Royal Society of Medicine , London and Fellow of American College of Clinical Pharmacology, USA. Dr. Marthak is actively involved with regulatory authorities like US FDA, UK MHRA, China SFDA, South Africa MCC, MHCW and India – DCGI.
He is Co- chairman Medical Committee IDMA and active member of Pharmaceutical Committee of CII. He is a Chairman of an Independent Ethics Committee- ISBEC. He has published many articles in International and National reputed journals.
Dr Netal Desai is the Vice President of Operations at Lambda Canada. Dr Desai has over 15 years of experience in Clinical Research and Pharmaceutical domain. Dr Desai joined Lambda family in 2008. His research experience includes design and management of early and late phase studies in Canada and India. Dr. Desai has successfully led numerous regulatory inspections from leading regulatory bodies. Dr. Desai is an MBBS and an MD in Pharmacology from M.S. University, India.
Dr. Copa joined Novum in 2013 to lead the Pharmacy Operations and the Client Services Division which oversees all Phase-I project management. He has more than 20 years of experience in contract research organizations, serving in a variety of roles ranging from director of Clinical Research to Site President, and most recently Chief Scientific Officer of a 554-bed clinical pharmacology unit (CPU). The CPU specialized in FIH studies, cardiac safety studies, bioequivalence studies and topical product studies.
Dr. Copa received his Doctor of Pharmacy degree from the University of Minnesota College of Pharmacy. He then completed a two-year fellowship in cardiovascular research and critical care medicine through the University of Minnesota.
Dr Tarak Parikh is a physician with rich experience of more than 16 years in Hospital and Clinical Research. He also possess a certificate in Pharmacovigilance. Dr. Tarak is looking after clinical operations for all the location (Ahmedabad, Mumbai & Mehsana) based in India. Prior to joining Lambda, Dr. Tarak Parikh experience includes working in Pharmaceutical companies like Alembic Pharma, Sun Pharma Ltd.. Where he contributed to develop BA/BE facility & Phase I unit. Dr.Tarak is well versed in Indian an International Regulatory guidelines applicable to Bioequivalence and Bioavailability studies & Phase I. He has faced various Indian & international regulatory audits
Dr. Coutinho obtained his M.D and MBA from the University of Toronto in 1988 and 2003, respectively. Dr. Coutinho has functioned as a qualified investigator since 2003 and is experienced in both Phase 1 and bioequivalence trials. Dr. Coutinho has also acted as a Medical Advisor for the Ministry of Health and Long-Term Care and the Workplace Safety and Insurance Board.